![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
|
|||||||||
Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK. |
| Parkinson's Disease |
|
Free Subscription
3 Ann Neurol |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Parkinson's Disease is free of charge.
Autonomic Dysfunction and Risk of Mortality in Early-Onset Parkinson's Disease.
Ann Neurol. 2025 Dec 31. doi: 10.1002/ana.78143.
PubMed
Abstract available
Speech Biomarkers From Smartphone Calls Track Progression in REM Sleep Behavior
Disorder and Parkinson's Disease.
Ann Neurol. 2025 Dec 30. doi: 10.1002/ana.78140.
PubMed
Abstract available
Age-Related Differences in the Association between REM Sleep and the Polygenic
Risk for Parkinson's Disease.
Ann Neurol. 2025 Dec 25. doi: 10.1002/ana.78112.
PubMed
Abstract available
Is the Medial Subthalamic Region in Humans Homologous to That in Rodents?
Relevance to Neuropsychiatric Disorders and Their Treatment With Deep Brain
Stimulation.
Biol Psychiatry. 2026;99:200-209.
PubMed
Abstract available
Association between inflammatory markers and Parkinson's disease risk: a
cross-sectional, propensity score-matched analysis of NHANES data.
BMC Neurol. 2025 Dec 27. doi: 10.1186/s12883-025-04598.
PubMed
Abstract available
Integrative analysis of mRNA and LncRNA profiles from small extracellular
vesicles identifies apoptosis-related biomarkers in patients with Parkinson's
disease after rehabilitation.
BMC Neurol. 2025 Dec 28. doi: 10.1186/s12883-025-04594.
PubMed
Molecular and neurochemical underpinnings of altered intrinsic neural timescales
in Parkinson's disease: a multimodal imaging and transcriptomics study.
Brain Res. 2025;1873:150133.
PubMed
Abstract available
LRRN3 protects dopaminergic neurons by inhibiting glycolysis in Parkinson's
disease.
Brain Res. 2025 Dec 19:150119. doi: 10.1016/j.brainres.2025.150119.
PubMed
Abstract available
Precision prevention for neurodegenerative diseases: lessons learnt from
Alzheimer's disease translated into perspectives for Parkinson's disease.
J Neural Transm (Vienna). 2025 Dec 26. doi: 10.1007/s00702-025-03090.
PubMed
Abstract available
Neuropathology in genetic Parkinson's disease: a focused review of pathological
and clinical findings.
J Neural Transm (Vienna). 2025 Dec 22. doi: 10.1007/s00702-025-03088.
PubMed
Abstract available
Influence of the level of education on cognitive function in Parkinson's disease.
J Neural Transm (Vienna). 2025 Dec 22. doi: 10.1007/s00702-025-03074.
PubMed
Abstract available
Dichotomous thinking in Parkinson therapy?
J Neural Transm (Vienna). 2025 Dec 22. doi: 10.1007/s00702-025-03089.
PubMed
Neuroprotective Effects of PEP-1-PGAM5 via the Attenuation of Oxidative Stress
and Apoptosis in Parkinson's Disease.
J Neurochem. 2025;169:e70324.
PubMed
Abstract available
Epigenetic ageing and the risk of Parkinson's disease.
J Neurol Neurosurg Psychiatry. 2025 Dec 30:jnnp-2025-336802.
PubMed
Abstract available
Integration of Volumetric, Iron, and Neuromelanin Magnetic Resonance Imaging
Measures Effectively Differentiates Parkinson's Disease from Multiple System
Atrophy.
Mov Disord. 2025 Dec 30. doi: 10.1002/mds.70153.
PubMed
Abstract available
The Race to Salvage Glucocerebrosidase: Understanding Small-Molecule Therapies
for GBA1-Associated Parkinsonism.
Mov Disord. 2025 Dec 29. doi: 10.1002/mds.70168.
PubMed
Abstract available
Pathogenic or Likely Pathogenic GRN Variants Are Found in 0.1% of Parkinson's
Disease Patients.
Mov Disord. 2025 Dec 24. doi: 10.1002/mds.70161.
PubMed
Abstract available
Genetic insights from Parkinson disease in African and African admixed
populations.
Nat Rev Neurol. 2026 Jan 2. doi: 10.1038/s41582-025-01177.
PubMed
Nuclear ASC speck formation in microglia is associated with inflammasome priming
and is exacerbated in LRRK2-G2019S Parkinson's disease.
Neurobiol Dis. 2025 Dec 25:107237. doi: 10.1016/j.nbd.2025.107237.
PubMed
Abstract available
Memory-guided saccade latency as a potential biomarker for axial symptoms and
freezing of gait in Parkinson's disease.
Neurobiol Dis. 2025 Dec 22:107238. doi: 10.1016/j.nbd.2025.107238.
PubMed
Abstract available
Wirelessly transmitted subthalamic nucleus signals decode endogenous pain levels
in Parkinson's disease patients.
Neurobiol Dis. 2025 Dec 22:107235. doi: 10.1016/j.nbd.2025.107235.
PubMed
Abstract available
Network-wide morphometric organization deficits and transcriptomic correlates in
Parkinson's disease with freezing of gait: A morphometric inverse divergence
study.
Neurobiol Dis. 2025 Dec 18:107230. doi: 10.1016/j.nbd.2025.107230.
PubMed
Abstract available
Schisanhenol Inhibits MPTP/MPP(+)-Induced Ferroptosis in Dopaminergic Neurons Via
Nrf2/TrxR1/GPX4 Pathway against Parkinson's Disease.
Neurochem Res. 2025;51:26.
PubMed
Abstract available
Comments on the article "Mortality rates for Parkinson's disease are increasing
in Spain. An age-period-cohort and joinpoint analysis of mortality rates from
1981 to 2020.".
Neurologia (Engl Ed). 2025 Dec 24:101893. doi: 10.1016/j.nrleng.2025.101893.
PubMed
Temporal Dynamics and Cross-Sectional and Longitudinal Factors Associated With
Motor Reserve and Outcome in Patients With Parkinson Disease.
Neurology. 2026;106:e214475.
PubMed
Abstract available
Investigations on the effects of SH2B2 on Parkinson's disease based on its in
vivo and in vitro neurotoxic model.
Neuroscience. 2025 Dec 31:S0306-4522(25)01236.
PubMed
Abstract available
Alterations of functional connectivity between hyperdirect pathway regions and
outside regions in Parkinson's disease patients with freezing of gait.
Neuroscience. 2025 Dec 23:S0306-4522(25)01225.
PubMed
Abstract available
Group singing through the lens of polyvagal theory: A pilot study in patients
with Parkinson's disease.
PLoS One. 2025;20:e0337210.
PubMed
Abstract available
Thank you for your interest in scientific medicine.